@misc{indiciae1bfb973a192e,
  title = {MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer},
  author = {Ellis, L. and German, B. and Singh, J. N. and Burkhart, D. L. and Sheahan, A. and Bergom, H. and Morel, K. L. and Beltran, H. and Hwang, J. and Lawrenson, K.},
  year = {2024},
  doi = {10.1101/2024.01.31.578216},
  url = {https://www.biorxiv.org/content/10.1101/2024.01.31.578216v1},
  note = {Source identifier: 10.1101/2024.01.31.578216}
}